Company News
Glenmark Board Meeting on May 29, 2026
Glenmark Pharmaceuticals board meeting scheduled for May 29, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
Board will consider recommending dividend for FY2026 on equi
